Adopting the prices of other countries could potentially have helped save Medicare part D as much as $72.8 billion in 2018, as drug prices in the U.S. averaged 3.2 to 4.1 times higher after rebates compared to the U.K., Japan and Ontario, Canada, according to a study published in Health Affairs.

Over the next 50 to 100 years, quantum computing will increasingly automate all manner of healthcare processes while biomaterials and genetic engineering drive regenerative medicine into everyday care.

Technology giant Tencent has begun a clinical trial in London of its AI program to diagnose Parkinson’s disease, Financial Times reported.

HHS has finalized a rule that will require drug companies to publish the list prices of drugs in television ads. 

CMS is taking steps to streamline the review process for states that apply for section 1915 waivers and state plan amendments, CMS Administrator Seema Verma announced May 7.  

Tennessee is poised to become the first state of the union to ask for Medicaid block granting from the Trump administration, Politico reported.

CVS Health is still facing challenges from its $69 billion merger with health insurance giant Aetna, which closed in late 2018. While the deal was approved by all necessary state regulators and the Department of Justice, a federal judge is still mulling over the deal and looking at potential antitrust problems.

There’s a lot of buzz about the applications of AI in the healthcare sector, but the innovations are still in infancy, leaving the potential use––and dangers––of AI in clinical settings unknown.

A machine learning tool for speech analysis has been shown capable of diagnosing childhood depression and anxiety with 80% accuracy.